Literature DB >> 18550608

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome.

P G Dambrava1, A Torres, X Vallès, J Mensa, M A Marcos, G Peñarroja, M Camps, R Estruch, M Sánchez, R Menéndez, M S Niederman.   

Abstract

The American Thoracic Society (ATS) published guidelines for the treatment and management of community-acquired pneumonia in 2001, but the impact of adherence on outcomes such as mortality and length of stay is not well defined. A study of 780 patients with community-acquired pneumonia consecutively admitted to hospital over 1 yr was carried out. Nursing home patients were excluded. Overall adherence to antibiotics recommended in the ATS guidelines was 84%. The lowest adherence was found in patients admitted to an intensive care unit (52%), especially those at risk of infection with Pseudomonas aeruginosa (ATS group IVb). However, very few patients from this group were indeed infected with P. aeruginosa. This could be explained by the exclusion of the nursing home patients. There was a difference in mortality between patients that received adherent and nonadherent regimens (3 versus 10.6%). There was a difference in length of stay between patients receiving adherent and nonadherent regimens (7.6 versus 10.4 days). This result was confirmed on multivariate analysis. Adherence to the 2001 American Thoracic Society guidelines was high except in community-acquired pneumonia patients admitted to an intensive care unit. Length of stay was shorter in patients who received adherent rather than nonadherent antibiotic regimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550608     DOI: 10.1183/09031936.00163407

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Severe community-acquired pneumonia and PIRO: a new paradigm of management.

Authors:  Jordi Rello; Thiago Lisboa; Richard Wunderink
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

2.  Identification of new risk factors for pneumonia: population-based case-control study.

Authors:  Yana Vinogradova; Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

3.  Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.

Authors:  Elisa Costantini; Elias Allara; Filippo Patrucco; Fabrizio Faggiano; Fozia Hamid; Piero Emilio Balbo
Journal:  Intern Emerg Med       Date:  2016-04-20       Impact factor: 3.397

4.  Using Standardized Care Bundles in the Emergency Department to Decrease Mortality in Patients Presenting with Community-Acquired Pneumonia (CAP) and Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).

Authors:  Pedro J Marcos; Arturo Huerta; Mark J Enzler
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

5.  Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia.

Authors:  Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

6.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.

Authors:  I Martin-Loeches; T Lisboa; A Rodriguez; C Putensen; D Annane; J Garnacho-Montero; M I Restrepo; J Rello
Journal:  Intensive Care Med       Date:  2009-12-02       Impact factor: 17.440

7.  Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.

Authors:  Rosario Menéndez; Antoni Torres; Soledad Reyes; Rafael Zalacain; Alberto Capelastegui; Olga Rajas; Luis Borderías; Juan J Martín-Villasclaras; Salvador Bello; Inmaculada Alfageme; Felipe Rodríguez de Castro; Jordi Rello; Luis Molinos; Juan Ruiz-Manzano
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

8.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

9.  Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.

Authors:  Francesco Blasi; Javier Garau; Jesús Medina; Marco Ávila; Kyle McBride; Helmut Ostermann
Journal:  Respir Res       Date:  2013-04-15

10.  Adherence to therapeutic guidelines for patients with community-acquired pneumonia in Australian hospitals.

Authors:  Nr Adler; Hm Weber; I Gunadasa; Aj Hughes; Nd Friedman
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2014-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.